Related Experiment Video
Updated: Jan 11, 2026
05:35
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.3K
Development and Implementation of a Nationwide Structured Education Programme for Type 1 Diabetes in India: The T1DE
Rajiv Singla1, Deep Dutta2, Vineet Surana3
1Consultant Endocrinology, Kalpavriksh Healthcare, Dwarka, Delhi, India.
Indian Journal of Endocrinology and Metabolism
|November 13, 2025
Summary
India
Area of Science:
- Endocrinology and Metabolism
- Medical Education
- Public Health Initiatives
Background:
- Structured diabetes education is crucial for type 1 diabetes (T1D) management.
- India lacks dedicated T1D educational programs for patients and healthcare professionals.
- The Type 1 Diabetes Education (T1DE) program was created to fill this gap.
Purpose of the Study:
- To develop and evaluate India's first large-scale, structured online education program for type 1 diabetes.
- To assess the effectiveness and participant engagement of the T1DE program.
Main Methods:
- A 10-session, free, online T1DE course delivered in regional languages.
- Utilized the ADDIE instructional design model for program development.
- Employed a mixed-methods evaluation including attendance, assessments, and feedback.
Main Results:
- 81.2% of 1023 registrants initiated the Type 1 Diabetes Education (T1DE) program.
- High pass rate (89.4%) among those who took the final test.
- Nutritionists and physicians showed high engagement and success; people with T1D had lower qualification rates.
- High participant and trainer satisfaction, but attrition remains a challenge.
Conclusions:
- The Type 1 Diabetes Education (T1DE) program is India's largest structured T1D educational initiative.
- Demonstrated significant knowledge gains for completers, highlighting program effectiveness.
- Future work needed on long-term outcomes and sustained participant engagement.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
01:15Diabetes: Management and Pharmacotherapy
853
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
853
01:16Insulin: Dosing Regimen and Adverse Effects
665
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
665
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
01:20Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K